ObjectivesThe opioid crisis has prompted consideration of analgesic prescriptions. This study explored the value of preoperative acetaminophen for pain control following microsuspension laryngoscopy (MSL) and compared the results with a previous study of pain and opioid use following MSL (Tsang et al.).MethodsA prospective open‐label clinical trial was conducted in patients undergoing MSL. All patients were administered preoperative acetaminophen. Short‐form McGill Pain Questionnaire (SF‐MPQ), pain visual analogue scale (VAS), and present pain intensity (PPI) scores were collected preoperatively and on postoperative days (PODs) 1, 3, 7, and 14. Statistical analysis identified variables associated with opioid use or increased pain scores, and compared outcomes with Tsang et al.ResultsEighty‐nine patients were included (mean age 52.8 ± 17.3 years, 40 males). All patients received preoperative 1 g acetaminophen (77 (86.5%) orally) with no adverse effects. On POD1, opioid usage was 10%. Median [IQR] pain scores were 5 [2–11], 21 [12.3–56.8], and 3 [2–3.3] on SF‐MPQ, VAS, and PPI, respectively. Post‐Anesthesia Care Unit (PACU) opioid requirements significantly correlated with POD1 opioid consumption (τb = 0.214; p ≤ 0.05), and significant associations with PACU opioid administration were found for total anesthesia time (OR (95%CI) = 1.271 (1.043–1.548), p = 0.017) and total laryngoscope suspension time (OR (95%CI) = 0.791 (0.651–0.962, p = 0.019)). This cohort demonstrated reduced opioid usage on POD1 compared with Tsang et al (23%).ConclusionsPreoperative acetaminophen is a safe intervention, resulting in decreased postoperative opioid use following MSL. Anesthesia time correlated with need for postoperative opioids.Level of EvidenceLevel 4 Laryngoscope, 2024